Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
-
First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab
-
Alkami to Announce Fourth Quarter 2023 Financial Results
-
Lulus to Report Fourth Quarter and Full Year 2023 Results on March 6, 2024
-
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
-
BBSI Sets Fourth Quarter and Full Year 2023 Conference Call for Wednesday, February 28, 2024, at 5:00 p.m. ET
-
GCM Grosvenor to Present at the UBS Financial Services Conference on February 28, 2024
-
Kyivstar and Come Back Alive Raise UAH180M to Demine Ukraine, Reaching Campaign Target
-
HEULIEZ secures contract to supply 200 e-buses to Marseille
-
NANO Nuclear Energy to Present and Exhibit at Innovation Zero 2024, the UK’s Largest Net Zero Conference
-
ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases
-
Clubhouse Media Group, Inc. Announces Miss Global Contestant, Patricia Rath, Joins HoneyDrip.com
-
“Strategic, deliberate” approach key to Canada’s international knowledge partnerships
-
BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET
-
Kornit Digital Reports Fourth Quarter and Full Year 2023 Results
-
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
-
Evoke Pharma Announces Closing of $7.5 Million Public Offering
-
CNH Industrial N.V. Reports Fourth Quarter and Full Year 2023 Results
-
Midland Provides an Overview of Its 2024 Exploration Activities With Its Partners and Also Follow-Up on Its New Discoveries
-
Medicenna Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Corporate Update
-
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2023 Earnings and Company Updates
-
Sekur Private Data Ltd. Launches Small Business Solutions Marketing Efforts Amid Increased Attacks on SMBs in the USA During Election Year
-
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
-
CoreCard Corporation Reports Fourth Quarter and Full Year 2023 Results
-
Conduent Recognized as a 2024 Leader in HR Benefits Administration by NelsonHall
-
DSM: Net Asset Value(s)
-
SFL - Fourth Quarter 2023 Results
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Alliance Trust PLC - Net Asset Value
-
Disclosure of transactions in the shares of Gabriel Holding A/S by persons discharging managerial responsibilities and closely related parties
-
Ladybug's Growhouse Nutraceuticals Ltd Reports Rapid Growth as Sales Continue to Accelerate Across All Product Lines
-
Ladybug's Growhouse Nutraceuticals Ltd Reports Rapid Growth as Sales Continue to Accelerate Across All Product Lines
-
Genesis Launches Web-based Middle-Office Solution for Equities and Fixed-Income Trading
-
Microbix Reports Record Results for Q1 Fiscal 2024
-
Perella Weinberg to Present at the Bank of America 2024 Financial Services Conference
-
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
-
Tower Semiconductor Reports 2023 Fourth Quarter and Full Year Financial Results
-
What is the Truth about Reconciliation? 2023 Year-End Review: Indigenous Watchdog
-
Mirasol Doubles the Sobek Copper-Gold Project in Vicuña District, Chile, through Option Agreement with SQM on Adjacent Rosita Property
-
Guardian Capital Announces February 2024 Cash Distributions for Guardian Capital ETFs
-
The Chefs’ Warehouse Reports Fourth Quarter 2023 Financial Results
-
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
-
KGI Securities Receives Membership Approval, Joins Abaxx Exchange as Clearing and Trading Member
-
PlanSource Charges into 2024 as Market Leader in Benefits Engagement, Personalization and Communication
-
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
-
Genius Group launches AI Avatar Tutor Team on GeniusU
-
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Tecnoglass Sets Date for Fourth Quarter and Full Year 2023 Results
-
Blue Point Brewing Announces Its 4th Annual Shakedown on Main Street Festival Featuring Headliners Shaggy, Bryce Vine, and B.o.B
-
Plug Announces Strategic Expense Reduction Plan to Save More Than $75 Million Annually
